Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:08 pm Purchase |
2020-12-31 | 13G | Stereotaxis, Inc. STXS |
Redmile Group LLC | 7,833,765 9.900% |
780,303 (+11.06%) |
Filing History |
| 2021-02-16 4:08 pm Purchase |
2020-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Redmile Group LLC | 3,412,009 9.900% |
471,120 (+16.02%) |
Filing History |
| 2021-02-16 4:08 pm Sale |
2020-12-31 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 2,123,492 5.700% |
-384,894 (-15.34%) |
Filing History |
| 2021-02-16 4:08 pm Sale |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,388,376 9.600% |
-22,281 (-0.65%) |
Filing History |
| 2021-02-16 4:08 pm Purchase |
2020-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,675,036 8.500% |
584,836 (+53.64%) |
Filing History |
| 2021-02-16 4:07 pm Purchase |
2020-12-31 | 13G | GENMARK DIAGNOSTICS INC GNMK |
Redmile Group LLC | 4,537,400 6.300% |
4,537,400 (New Position) |
Filing History |
| 2021-02-16 4:07 pm Sale |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 4,437,968 7.800% |
-271,530 (-5.77%) |
Filing History |
| 2021-02-16 4:07 pm Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Redmile Group LLC | 2,711,616 6.900% |
2,711,616 (New Position) |
Filing History |
| 2021-02-16 4:07 pm Purchase |
2020-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Redmile Group LLC | 1,378,319 5.700% |
1,378,319 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Beam Therapeutics Inc. BEAM |
Redmile Group LLC | 3,778,262 6.500% |
3,778,262 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 667,816 5.200% |
667,816 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | AVITA Medical, Inc. RCEL |
Redmile Group LLC | 1,707,386 7.900% |
1,707,386 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Atreca, Inc. BCEL |
Redmile Group LLC | 2,476,068 8.260% |
1,339,262 (+117.81%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Redmile Group LLC | 63,436 5.990% |
-50,000 (-44.08%) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 3,448,030 9.040% |
3,448,030 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 22,125,489 8.500% |
-3,357,280 (-13.17%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Allakos Inc. ALLK |
Redmile Group LLC | 2,667,451 5.080% |
-366,075 (-12.07%) |
Filing History |
| 2021-02-16 4:05 pm Purchase |
2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Redmile Group LLC | 2,322,557 6.690% |
2,322,557 (New Position) |
Filing History |
| 2021-02-16 4:05 pm Purchase |
2020-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 6,758,794 8.810% |
6,758,794 (New Position) |
Filing History |
| 2021-01-12 4:18 pm Purchase |
2021-01-08 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 12,993,888 14.100% |
332,152 (+2.62%) |
Filing History |